Akt1-IN-8

Akt1-IN-8 (Compound JL18) is a potent and oral bioavailable (41%) inhibitor of AKT1 kinase, with an IC50 of 8.8 nM. Akt1-IN-8 exhibits significant antiproliferative effects against PC-3 prostate cancer cells, with an IC50 of 3.0 μM. Akt1-IN-8 can reduce phosphorylated GSK3β levels.

For research use only. We do not sell to patients.

  • CAS No.: 2247688-87-3
  • Formula: C21H25Br2N7O
  • Molecular Weight:551.28
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Akt Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00